To evaluate the replication capacity and phenotypic susceptibility to dolutegravir and raltegravir of wild-type and raltegravir-resistant HIV-1 strains in several cellular systems.
Pollicita, M., Surdo, M., DI SANTO, F., Cortese, M., Fabeni, L., Fedele, V., et al. (2014). Comparative replication capacity of raltegravir-resistant strains and antiviral activity of the new-generation integrase inhibitor dolutegravir in human primary macrophages and lymphocytes. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 69(9), 2412-2419 [10.1093/jac/dku144].
Comparative replication capacity of raltegravir-resistant strains and antiviral activity of the new-generation integrase inhibitor dolutegravir in human primary macrophages and lymphocytes
POLLICITA, MICHELA;DI SANTO, FABIOLA;CECCHERINI SILBERSTEIN, FRANCESCA;PERNO, CARLO FEDERICO;SVICHER, VALENTINA
2014-05-23
Abstract
To evaluate the replication capacity and phenotypic susceptibility to dolutegravir and raltegravir of wild-type and raltegravir-resistant HIV-1 strains in several cellular systems.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Svicher_RAL_JAC14.pdf
accesso aperto
Licenza:
Copyright dell'editore
Dimensione
320.37 kB
Formato
Adobe PDF
|
320.37 kB | Adobe PDF | Visualizza/Apri |
|
Svicher_RAL_JAC14.pdf
accesso aperto
Licenza:
Copyright dell'editore
Dimensione
320.37 kB
Formato
Adobe PDF
|
320.37 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
